Fertility desires, choice of hormone replacement and the effect of length of time since menopause on bone density in women with premature ovarian insufficiency: A review of 223 consecutive new referrals to a tertiary centre

Post Reproductive Health

Volumn 20, Issue 3, 2014, Pages 104-111

  Mittal, Monica ^a   Kreatsa, Maria ^a   Narvekar, Nitish ^a   Savvas, Michael ^a   Hamoda, Haitham ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Estrogen; Hormone replacement therapy; Menopause; Osteoporosis; Vasomotor symptoms

Indexed keywords

ESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; FEMALE; FERTILITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SYMPTOM ASSESSMENT; TREATMENT DURATION; COMPLICATION; ESTROGEN THERAPY; INFERTILITY, FEMALE; OSTEOPOROSIS, POSTMENOPAUSAL; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; PSYCHOLOGY; WOMEN'S HEALTH; YOUNG ADULT;

ADULT; BONE DENSITY; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; OSTEOPOROSIS, POSTMENOPAUSAL; PRIMARY OVARIAN INSUFFICIENCY; RETROSPECTIVE STUDIES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 84929513894     PISSN: 20533691     EISSN: 20533705     Source Type: Journal    
DOI: 10.1177/2053369114539151     Document Type: Article

References (24)

1. Maclaran K, Horner E and Panay N. Premature ovarian failure: long term sequelae. Menopause Int 2010; 16: 38-41.
2. De Vos M, Devroey P and Fauser BCJM. Primary ovarian insufficiency. The Lancet 2010; 376: 911-921.
3. De Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013; 16: 316-337.
4. Schmidt P. The 2012 Hormone therapy position statement of the North American Menopause Society. Menopause: J N Am Menopause Soc 2012; 19: 257-271.
5. Panay N, Hamoda H, Arya R, et al. The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy. Menopause Int 2013; 19: 59-68.
6. Pitkin J, Rees MCP, Gray S, et al. Writing Group for the British Menopause Society Council: British Menopause Society Council Consensus Statement, Management of premature menopause. Menopause Int 2007; 13: 44-45.
7. Cartwright B, Robinson J and Rymer J. Treatment of premature ovarian failure trial: description of an ongoing clinical trial. Menopause Int 2010; 16: 18-22.
8. Van Kasteren YM and Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999; 5: 483-492.
9. Oktay K, Cil AP and Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertility and Sterility 2006; 86: 70-80.
10. Donnez J, Dolmans MM, Demylle D, et al. Live birth after orthotopic transplantation of cryopreserved ovarian tissue. The Lancet 2004; 364: 1405-1410.
11. Prasath EB. Ovarian tissue cryopreservation: An update. J Hum Reprod Sciences 2008; 1: 50-55.
12. Dolmans MM, Jadoul P, Gilliaux S, et al. A review of 15 years of ovarian tissue bank activities. J Assisted Reprod Genetics 2013; 30: 305-314.
13. Li J, Kawamura K, Cheng Y, et al. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci 107: 10280-10284.
14. Kawamura K, Cheng Y, Suzuki N, et al. Hippo signalling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci 2013; 110: 17474-17479.
15. Yeung TWY, Li RHW, Lee VCY, et al. A randomized double-blinded placebo-controlled trial on the effects of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency. J Clin Endocrin Metab 2013; 98: 380-388.
16. Goswami D and Conway GS. Premature ovarian failure. Hum Reprod Update 2005; 11: 391-410.
17. Panay N and Kalu E. Management of premature ovarian failure. Best Prac & Res Clin Obstet Gynaec 2009; 23: 129-140.
18. Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Women’s Health 2012; 21: 161-169.
19. Vrablik M, Fait T, Kovar J, et al. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Metabolism 2008; 57: 1088-1092.
20. Renoux C, Dell’Aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010; 340: 1-7.
21. Renoux C, Dell’Aniello S and Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thrombosis Haemostasis 2010; 8: 979-986.
22. Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007; 14: 567-571.
23. Stavraka C, Maclaran K, Gabra H, et al. A study to evaluate the cause of bone demineralisation in gynaecological cancer survivors. The Oncologist 2013; 18: 1-7.
24. https://poiregistry.net/ (2014, accessed 7 May 2014).